Neurofolin® was launched in Melbourne, Australia and has been extremely well-received by the public, media and most importantly healthcare professionals.
Coinciding with the launch, research presented at the Australian Society for Bipolar & Depressive Disorders Conference showed that adding Neurofolin® (L-methylfolate 15mg) to standard prescription medications for depression can significantly increase the proportion of patients that respond positively.
Professor Mal Hopwood, Professor of Psychiatry at the University of Melbourne and the Immediate Past President of Royal Australian and New Zealand College of Psychiatrists, says it is promising to see new options being made available to Australians with depression
“Given we have an estimated 2 million Australians affected by depression, many of whom will not respond to current treatments, new options are always very welcome. It is important for Australians with depression to speak with their primary healthcare professionals to discuss options on how to optimise their existing treatment,” said Professor Hopwood
Dr Darryl Bassett, a Perth-based psychiatrist and formerly Adjunct Professor of Psychiatry at the University of Notre Dame and Clinical Associate Professor of Psychiatry at the University of Western Australia, says one of the keys to better treatment outcomes in depression is increasing response rates.
“There is certainly a trend globally in depression treatment towards augmenting medications with specialised nutritional support to improve the number of people who benefit. The data from the conference certainly shows how promising that approach is likely to be,” said Dr Bassett.
Below are some further links to recent media coverage.
|Mammia||Colbey had depression for years. Then a little-known supplement pulled him out of the darkness.|
|9 News||Folate supplement showing promise in the treatment of depression|
|7 News||Affecting more than a million Australians|
|TEN Eyewitness News||Food for thought|
|Body+Soul||A once-a-day drink could help treat depression|
|Pharmacy Guild of Australia ITK Connect||New dietary option supports depression treatment for Australians|
|Pharmacy Daily||Folate depression link|
|Pharmacy News||Supplement boosts effectiveness of SSRIs|
|2CC news radio (Canberra)||A new medical supplement could improve response rates to depression|
|2GB new radio (Sydney)||A new medical supplement could improve response rates to depression|
|6PR new radio (Perth)||A medical supplement is helping people suffering from depression to respond positively to treatments|
Contact Grünbiotics media relations
If you are a journalist with a media enquiry, please write to us at email@example.com and we will respond to your request as soon as possible.
If you are a consumer, healthcare professional, investor, or member of the public please visit the Contact Us page or call Grünbiotics on: +613 8692 0006.